We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Parkinson's Protein Is an Interface Between the Brain and Immune System

Read time: 1 minute

Mutations in the Parkin gene are a common cause of hereditary forms of Parkinson’s disease. Similar to Parkin, the neighboring Parkin Co-Regulated Gene PACRG regulates a signaling pathway that plays an important role in the innate immune system. This was discovered by a team of researchers led by Professor Konstanze Winklhofer from the Department of Molecular Cell Biology at Ruhr-Universität Bochum (RUB). The team was thus able to provide further evidence that there are interfaces between the nervous system and immune system. The researchers hope that the protagonists or antagonists of this signaling pathway may be suitable for therapeutic interventions.

Genes protect nerve cells against cell death

The Parkin gene protects nerve cells against functional impairment and cell death. It particularly ensures that mitochondria, cell organelles that are responsible for energy production, remain intact and that damaged mitochondria are removed. PACRG is located next to the Parkin gene in the genome. Both genes share what is called a promotor, which regulates the expression of the genes. Parkin and PACRG are thus expressed in a similar pattern.

"Little has been known about PACRG so far, so we investigated what functions this gene has," says Winklhofer. Her team found that, unlike Parkin, PACRG has no influence on the elimination of damaged mitochondria, but, like parkin, is able to protect nerve cells from cell death.

Parkin and PACRG regulate a signaling pathway of the innate immune system

Further investigations into the mechanism of action showed that PACRG regulates a signaling pathway that is stimulated by tumor necrosis factor (TNF). This results in the activation of the transcription factor NF-κB, which ensures the increased formation of pro-survival proteins. Both Parkin and PACRG have an effect on an essential protein complex of this signaling pathway, called Lubac (linear ubiquitin chain assembly complex). Lubac is required for efficient signal transduction by modifying components of the NF-κB signaling pathway with linear ubiquitin chains.

The TNF-NF-κB signaling pathway not only regulates cell death but also plays an important role in the innate immune system. It prevents the spreading of certain bacteria that invade host cells, such as salmonella, linked to foodborne infections, or mycobacteria, which cause tuberculosis or leprosy. "Interestingly, sequence variations in the Parkin and PACRG genes have been described that lead to an increased susceptibility to these bacterial infections and are associated with severe courses of salmonella or mycobacterial infections," explains Winklhofer. The current findings thus provide a plausible explanation for these observations and confirm that there are interfaces between the nervous system and immune system. Their protagonists or antagonists could be suitable targets for therapeutic interventions.

Reference

Meschede et al. (2020) The parkin-coregulated gene product PACRG promotes TNF signaling by stabilizing LUBAC. Science Signaling. DOI: https://doi.org/10.1084/jem.20190915

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.